Anna Angelousi
Overview
Explore the profile of Anna Angelousi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Catalano R, Nozza E, Altieri B, Esposito E, Croci G, Barbieri A, et al.
Cell Commun Signal
. 2025 Mar;
23(1):119.
PMID: 40038716
Background: The insulin-like growth factor 2 (IGF2) is overexpressed in 90% of adrenocortical carcinomas (ACC) and promotes cell proliferation via IGF1R and isoform A of insulin receptor (IRA). However, IGF2...
2.
Mytareli C, Kalotychou V, Lafioniatis A, Kaltsas G, Zografos G, Markou A, et al.
Front Endocrinol (Lausanne)
. 2025 Feb;
16:1511520.
PMID: 39950028
Introduction: Adrenal tumors (ATs) encompass a wide differential diagnosis, necessitating a multi-step process for accurate identification. Liquid biopsy emerges as a promising non-invasive technique for distinguishing between malignant and benign,...
3.
Angelousi A, Alexandraki K, Kassi E, Kaltsas G
Eur J Endocrinol
. 2024 Nov;
191(6):R5-R7.
PMID: 39602245
No abstract available.
4.
Tsiakas S, Angelousi A, Benetou V, Orfanos P, Xagas E, Boletis J, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597857
Glucocorticoids are commonly used for maintenance immunosuppressive therapy in kidney transplant recipients (KTRs). We aimed to investigate the prevalence of hypothalamic-pituitary-adrenal (HPA) axis suppression and its association with metabolic disorders...
5.
Angelousi A, Jouinot A, Bourgioti C, Tokmakidis P, Bertherat J, Kaltsas G
JCEM Case Rep
. 2024 Jul;
2(8):luae131.
PMID: 39081696
The transformation of an adrenocortical adenoma (ACA) to an adrenocortical carcinoma (ACC) is extremely rare. Current guidelines suggest against further imaging studies and follow-up in patients with nonfunctional adrenal incidentalomas...
6.
Xekouki P, Venetsanaki V, Kyriakopoulos G, Alexandraki K, Angelousi A, Kaltsas G
Endocr Rev
. 2024 Jul;
45(6):880-911.
PMID: 39058900
The parasellar region is the anatomical area around the sella turcica that represents a crucial crossroad for important adjacent structures. Several distinct tumors can primarily originate from this area, the...
7.
Angelousi A, Ziogas D, Siampanopoulou V, Mytareli C, Anastasopoulou A, Lyrarakis G, et al.
Diseases
. 2024 Feb;
12(2).
PMID: 38391787
Background: Checkpoint inhibitor (CPI)-associated diabetes mellitus (CPI-DM) is a rare immune-related adverse event (irAE) that presents with variable clinical manifestations. Data about its pathogenesis have not yet been adequately studied....
8.
Angelousi A, Tzoulis P, Tsoli M, Chatzellis E, Koumarianou A, Kaltsas G
Endocr Relat Cancer
. 2024 Jan;
31(4).
PMID: 38235757
Immunotherapy has revolutionised the treatment of oncological patients, but its application in various endocrine tumours is rather limited and is mainly used when conventional therapies have failed. Immune checkpoint inhibitors...
9.
Catalano R, Altieri B, Angelousi A, Arosio M, Bravi F, Canu L, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38068896
The insulin-like growth factor 2 (IGF2) promotes cell growth by overactivating the IGF system in an autocrine loop in adrenocortical carcinomas (ACCs). The cytoskeleton protein filamin A (FLNA) acts as...
10.
Mourelatos P, Vrettou C, Diamantopoulos A, Vassiliou A, Jahaj E, Angelousi A, et al.
Hormones (Athens)
. 2023 Nov;
23(1):59-67.
PMID: 37996650
Objective: To investigate hormonal status in patients with long-COVID and explore the interrelationship between hormone levels and long-COVID symptoms. Design: Prospective observational study. Participants: Patients who visited our long-COVID outpatients'...